Ascendis Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.About ASND
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs.
CEOJan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees—
Employees—
HeadquartersHellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded2006
Founded2006
Employees—
Employees—
ASND Key Statistics
Market cap12.24B
Market cap12.24B
Price-Earnings ratio-47.21
Price-Earnings ratio-47.21
Dividend yield—
Dividend yield—
Average volume543.26K
Average volume543.26K
High today—
High today—
Low today—
Low today—
Open price$201.16
Open price$201.16
Volume0.00
Volume0.00
52 Week high$223.19
52 Week high$223.19
52 Week low$118.03
52 Week low$118.03
Stock Snapshot
With a market cap of 12.24B, Ascendis Pharma(ASND) trades at $200.50. The stock has a price-to-earnings ratio of -47.21.
Ascendis Pharma(ASND) stock opened on 2025-12-04 at $201.16. The price climbed to — and dipped to —.
Ascendis Pharma(ASND) shares are trading with a volume of 0, against a daily average of 543.26K.
During the past year, Ascendis Pharma(ASND) stock moved between $118.03 at its lowest and $223.19 at its peak.
During the past year, Ascendis Pharma(ASND) stock moved between $118.03 at its lowest and $223.19 at its peak.
ASND News
Simply Wall St 6d
FDA Review Delay for TransCon CNP Might Change the Case for Investing in Ascendis PharmaAscendis Pharma recently announced that the U.S. FDA extended the Prescription Drug User Fee Act (PDUFA) target action date for its TransCon CNP therapy in chil...
Analyst ratings
100%
of 15 ratingsBuy
100%
Hold
0%
Sell
0%